D-0270-2022 Class III Terminated
FDA drug recall D-0270-2022 was initiated by Dr. Reddy's Laboratories, Inc. on Nov 12, 2021 and is designated Class III. Reason for recall: Failed dissolution specifications The recall status is terminated (terminated Jun 23, 2023). Affected quantity: 2352 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 15, 2021
- Initiation Date
- Nov 12, 2021
- Termination Date
- Jun 23, 2023
- Product Quantity
- 2352 cartons
Product description
Antihistamine & Nasal Decongestant, Fexofenadine HCl 60 mg and Pseudoephedrine HCl 120 mg, Extended Release Tablets USP, Allergy & Congestion, 12 Hour, 20 Tablets, Distributed by: Rugby Laboratories, 17177 N. Laurel Park Drive, Suite 233, Livonia, MI 48152, www.rugbylaboratories.com. NDC 0536-1242-34.
Reason for recall
Failed dissolution specifications
Distribution pattern
USA Nationwide.
Code information
Lot #: AC2103329H, Exp 1/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0270-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026